Gross Profit Margin (Quarterly) Chart

View Gross Profit Margin (Quarterly) for VTIAF.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Gross Profit Margin (Quarterly) Chart
Start Trial

Historical Gross Profit Margin (Quarterly) Data

View and export this data back to 2006. Start Trial.
Date Value
March 31, 2026 59.60%
December 31, 2025 88.95%
September 30, 2025 42.88%
June 30, 2025 41.60%
March 31, 2025 61.12%
December 31, 2024 67.95%
September 30, 2024 40.64%
June 30, 2024 38.11%
March 31, 2024 37.52%
December 31, 2023 33.77%
September 30, 2023 43.80%
June 30, 2023 36.70%
March 31, 2023 31.73%
December 31, 2022 -58.73%
September 30, 2022 32.09%
June 30, 2022 23.03%
March 31, 2022 23.20%
December 31, 2021 21.10%
September 30, 2021 60.29%
June 30, 2021 56.88%
March 31, 2021 58.09%
December 31, 2020 55.02%
September 30, 2020 59.84%
June 30, 2020 57.50%
March 31, 2020 56.15%
Date Value
December 31, 2019 60.94%
September 30, 2019 64.89%
June 30, 2019 62.73%
March 31, 2019 60.38%
December 31, 2018 61.10%
September 30, 2018 60.13%
June 30, 2018 55.76%
March 31, 2018 57.72%
December 31, 2017 58.97%
September 30, 2017 53.23%
June 30, 2017 53.13%
March 31, 2017 60.01%
December 31, 2016 53.81%
September 30, 2016 57.09%
June 30, 2016 51.43%
March 31, 2016 49.20%
December 31, 2015 16.85%
September 30, 2015 55.12%
June 30, 2015 58.35%
March 31, 2015 56.86%
December 31, 2014 56.01%
September 30, 2014 57.93%
June 30, 2014 56.45%
March 31, 2014 58.01%
December 31, 2013 63.79%

Gross Profit Margin Definition

Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.

Read full definition.

Gross Profit Margin (Quarterly) Range, Past 5 Years

View Gross Profit Margin (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Gross Profit Margin (Quarterly) Benchmarks

View Gross Profit Margin (Quarterly) Benchmarks
Start Trial
Fresenius Medical Care AG 26.95%
Global Cord Blood Corp. --
Cryo-Cell International, Inc. 76.07%
Rhön-Klinikum AG -4.65%
Cordlife Group Ltd. 56.96%

Gross Profit Margin (Quarterly) Related Metrics